Surgical Treatment of Malignant Nonfunctioning Neuroendocrine Tumors of the Pancreas

Shkarban, V. P.; Nichitaylo, M. E.; Scums, A.

doi:10.1093/annonc/mdt203.170

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Основным методом лечения нейроэндокринных опухолей поджелудочной железы вне зависимости от дифференцировки является хирургическое вмешательство [3, [10][11][12]. Объем оперативного лечения определяется в зависимости от размеров и локализации опухоли, функционального статуса опухоли, наличия метастазов и осложнений опухолевого процесса.…”

Section: актуальностьunclassified

Treatment of Patients With Pancreatic Neuroendocrine Tumours Depending on the Differentiation Grade

et al. 2019

View full text Add to dashboard Cite

The incidence of neuroendocrine tumors has significantly increased over the last years.The purpose of the study was to analyze treatment outcomes in patients with pancreatic endocrine tumors (PETs) with regard to histopathologic diagnosis.Material and Methods. The clinical records of 1077 patients with pancreatic tumors were retrospectively analyzed. Fifty patients were diagnosed with PET. Treatment outcomes were assessed with regard to tumor differentiation grade, tumor stage, extent of surgery and drug therapy.Results. The most common histological grade was G1. Patients with G1 tumors had the best 1-and 3-year survival rates regardless of tumor stage. Factors influencing prognosis in patients with PETs were: radical surgery, Ki67 expression level, histological grade (G1–3), tumor stage at diagnosis.

show abstract

Section: актуальностьunclassified